Connect with us
Information
About Us
Contact Us
Careers
Partnerships
Advertise With Us
Authors
Browse Topics
Events
Disclaimer
Privacy Policy
NORTH AMERICA EDITION
Australia
North America
World
Login
Investing News
Network
Your trusted source for investing success
NORTH AMERICA EDITION
North America
Australia
World
My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
Reports & Guides
Market Outlook Reports
Investing Guides
Resource
Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals
Tech
Life Science
aldeyra therapeutics
POPULAR ARTICLES
Aldeyra Therapeutics Reports Full-Year 2019 Financial Results
Aldeyra Therapeutics Reveals Results from ADX-102 Trial
Aldeyra Therapeutics Shares Financials for Q1 2017
LATEST ARTICLES
Aldeyra Gets First Patient Enrolled in Phase 3 Trial
Aldeyra Gets Orphan Drug Designation for ADX-102
Aldeyra Doses Last Patient in Allergic Conjunctivitis Trial
Aldeyra Therapeutics, Inc. Prices Public Offering of Common Stock
Aldeyra Therapeutics Announces Clinical Development Update for Phase 3 Programs
Aldeyra Therapeutics Announces Third Quarter 2016 Financial Results
Aldeyra Therapeutics Appoints Richard H. Douglas to Board of Directors
Latest News
CEOL Application Process Update
Riverside Resources Receives Final Court Approval for Spin-Out of Blue Jay
Silver47 Announces Its Final Closing of $9.8 Million Non-Brokered Private Placement
Galan Declines AU$240M Bid for Argentina Projects
Close of Takeover Offer
More News
